This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $39,996.51 firm-fixed-price contract is for the supply of REVATIO 20 MG TABLET 90S, a medication used to treat pulmonary arterial hypertension.
The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order. The contract has an ultimate completion date of December 9, 2024.
This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 10:01 AM